Niostem

Koln, Germany Founded: 2019 • Age: 7 yrs
Smart wearable devices for hair regrowth are provided by Niostem.

About Niostem

Niostem is a company based in Koln (Germany) founded in 2019 by Emil Aliev and Carlos A Chacon Martinez. Niostem has raised $1.94 million across 1 funding round from investors including Brightlands Venture Partners. Niostem offers products and services including niostem Wearable. Niostem operates in a competitive market with competitors including Avita Medical, Quality by Design, Suneva Medical, MoMelan Technologies and LifeCell, among others.

  • Headquarter Koln, Germany
  • Founders Emil Aliev, Carlos A Chacon Martinez
  • Sectors
    Healthcare
  • Website category Computers Electronics and Technology · Social Networks and Online Communities
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website niostem.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Mane Biotech Gmbh
Key Metrics

Products & Services of Niostem

Niostem offers a comprehensive portfolio of products and services, including niostem Wearable.

niostem Wearable
Hair Regrowth Device

Uses bioelectrical stimulation to promote hair follicle growth and density.

Apps and channels of Niostem

Niostem publishes 2 mobile apps with over 1K+ downloads; its YouTube channel niostem has 395 subscribers and 13 videos.

niostem
Google Play Health & Fitness Everyone Free
Developer: ManeBiotech
View on Google Play
niostem
App Store Health & Fitness 17+
Developer: Mane Biotech GmbH
View on App Store
niostem
YouTube 395 subscribers 13 videos Science & Technology
Open channel

Videos from Niostem

The most watched videos on Niostem's YouTube channel, niostem (395 subscribers). Click a video to play it here.

niostem | Indiegogo
25.8K views
Kunden-Erfahrungsberichte zu niostem: Antworten auf eure Fragen!
15.5K views
How does niostem work? | With Carlos Chacón-Martínez, PhD - CEO & co-founder | Indiegogo
4.6K views
Fireside Chat with niostem Founder Carlos Chacón-Martínez - Episode 1
1.5K views

More on niostem.

Funding Insights of Niostem

Niostem has successfully raised a total of $1.94M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.94 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.94M
  • Total Rounds 1
  • Last Round Seed — $1.94M
  • First Round $1.94M

    (Jan 2022)

  • Investors Count 1

All 1 funding rounds of Niostem with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2022$1.94MSeed–Brightlands Venture Partners
–
Valuation history

1 investors in total: 1 institutional.

Investors in Niostem

Niostem has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Brightlands Venture Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Brightlands Venture Partners is focused on venture capital investments.
–brightlandsventurepartners.comGeleen, Netherlands
Premium access

Investor details for Niostem

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Niostem

4 people are tracked at Niostem (4 in leadership).

NameRoleGroup
Emil Aliev
Co-FounderLeadership
Carlos A Chacon Martinez
Co-Founder & CEOLeadership
Carlos A. Chacón-Martínez
CEO & Co-FounderLeadership
Gleb Pogorelov
Head Of ProductionLeadership
Premium access

Complete people profiles for Niostem

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Niostem

2 dated milestones of Niostem across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Niostem is founded.
  2. Funding First funding round of $1.9M.

Competitors of Niostem

Niostem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avita Medical, Quality by Design, Suneva Medical, MoMelan Technologies and LifeCell, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
avitamedical.com1992Cambridge, United Kingdom–108
Products for regenerative and respiratory medicine are developed and distributed.
collagensolutions.com2014London, United Kingdom–44
Medical grade collagen components are developed and manufactured.
sunevamedical.com2009San Diego, United States$154.8M94
Novel aesthetic products for regenerative markets are developed and commercialized.
momelan.com2009Cambridge, United States$8.75M–
Skin grafting technology for dermatological diseases and wound care
lifecell.com1986United States$14M–
Tissue repair products for regenerative medicine are developed and marketed.
lpgsystems.com1986Valence, France––
Developer of cellular stimulation equipment
siliconeartslabs.com2010Memphis, United States$2.55M–
Replica of human eye and Scar filler to fill skin defects
celltrix.se2004Malma, Sweden$3.81M–
Specializes in reconstructive cosmetic surgery products for medical professionals.
Premium access

Detailed competitors of Niostem

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Niostem

The website of Niostem (niostem.com) receives about 14.5K visits a month and ranks #1,451,563 among all websites worldwide, #7,735 in Social Networks and Online Communities.

  • Monthly visits
    14.5K
  • Unique visitors
    5.4K

    per month

  • Global rank
    #1,451,563

    among all websites

  • Category rank
    #7,735

    Computers Electronics and Technology · Social Networks and Online Communities

Latest news on Niostem

Premium access

Complete news archive for Niostem

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Niostem

10 companies that operate in the same segment as Niostem (Dermatology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
2002Newark, New Jersey, United StatesUSD 154.56 MUSD 234.04 M597
Diagnostic tests for cancer prognosis are provided.
2008Friendswood, Texas, United StatesUSD 61.97 MUSD 344.23 M761
Developer of drugs for treating dermatology diseases
1908Copenhagen, DenmarkUSD 560.38 M––
Skincare, beauty, and wellness services provided by VLCC across multiple countries.
1989Delhi, Delhi, India–––
Adhesive patch biopsies for skin cancer detection are provided.
1996San Diego, California, United StatesUSD 24.37 MUSD 15.3 M259
AI-powered drug discovery platform for various diseases
2016New York, New York, United StatesUSD 608 M––
Immunotherapeutic solutions for dermatological conditions are developed.
2016Westlake Village, California, United StatesUSD 94.5 MUSD 376.07 M342
Targeted small molecules are developed for oncology treatments.
2010Singapore, SingaporeUSD 100 M––
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured.
2014Pune, Maharashtra, IndiaUSD 25.97 MUSD 18.15 M508
Novel dermatologic therapies are developed for skin conditions.
2012Malvern, Pennsylvania, United StatesUSD 82 MUSD 7.83 M64
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Niostem

Niostem was founded in 2019 and raised its 1st funding round 3 years after it was founded.

Niostem is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.

Carlos A Chacon Martinez is the current CEO of Niostem. They have also founded this company.

Niostem is a funded company, having raised a total of $1.94M across 1 funding round to date. The company's 1st funding round was a Seed of $1.94M, raised on Jan 2022.

Provider of smart wearable device to regrow hair. The company has developed nio1 a smart wearable device to combat pattern baldness that uses low-level bioelectrical stimulation to the scalp to trigger the natural growth cycle of the body.

Niostem's top competitors include Avita Medical, Quality by Design and Suneva Medical.

Niostem offers niostem Wearable.

Niostem has 1 investor. Key investors include Brightlands Venture Partners.

Niostem operates through Mane Biotech Gmbh.

Yes. Niostem publishes niostem and 1 more app, with over 1,000 downloads.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available